Drug on Urinary Sodium Excretion Response to Mental Stress
Study Description
“Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress”
The purpose of this study is to determine if stopping the stress induced increase in inflammation will prevent sodium retention which in turn increases blood pressure. Each subject will test two separate times. One week, they will be taking a daily dose of mycophenolate mofetil (MMF), the other week they will be taking a placebo.
Location
Methods
Pharmaceutical medication involved
Patients and healthy individuals accepted
Drug - mycophenolate mofetil (MMF)
an immunosuppressant - 500 mgs twice a day for 7 1/2 days - in capsule form
Drug - Placebo
a sugar pill - 500 mgs twice a day for 7 1/2 days - in the same capsule form as the MMF
Additional Information
Official Study Title
Comparing the Effects of an Immunosuppressant (Mycophenolate Mofetil or MMF) on the Urinary Sodium Excretion Response to Mental Stress in a Crossover Design (MMF)
Clinical Trial ID
NCT02432339
ParticipAid ID
BeXY8a
